<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04956848</url>
  </required_header>
  <id_info>
    <org_study_id>1571 - KiDA</org_study_id>
    <nct_id>NCT04956848</nct_id>
  </id_info>
  <brief_title>Comparing KIDScore™ D5 and iDAScore®. The KiDA Study</brief_title>
  <official_title>A Comparison of Two Models Used for Identifying Embryos With the Best Chance of Inducing Pregnancy: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vitrolife</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vitrolife</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A pilot study to gather information on clinical pregnancy rates for preparation of the&#xD;
      planning of a larger randomized controlled trial comparing two decision support tools: the&#xD;
      deep learning tool iDAScore® and the current annotation model, KIDScore™ D5.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2021</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A pilot study randomizing embryos into two study groups comparing two decision support tools in the ranking of embryos for transfer.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>After 6 weeks of gestation</time_frame>
    <description>Ultrasound evidence of an intrauterine pregnancy with a fetal heart observed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Positive hCG rate per randomized patient</measure>
    <time_frame>From day 13 following embryo transfer</time_frame>
    <description>An hCG measurement using urinary sticks with a sensitivity of 25 IU/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of non-viable intrauterine pregnancies per randomized patient</measure>
    <time_frame>After 6 weeks of gestation</time_frame>
    <description>Ultrasound evidence of an intrauterine pregnancy but with no fetal heart observed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical pregnancy rate in patients with maternal age above 35</measure>
    <time_frame>After 6 weeks of gestation</time_frame>
    <description>Ultrasound evidence of an intrauterine pregnancy with a fetal heart observed</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>IVF</condition>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Embryo selection supported by KIDScore™ D5</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Each embryo reaching at least developmental stage of 3BB will annotated by an embryologist using the parameters required by the KIDScore™ D5. The embryo with the highest KIDScore™ will be selected proposed for transfer.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Embryo selection supported by iDAScore®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Images of all the embryos reaching at least developmental stage of 3BB will be analyzed by iDAScore®. The embryo with the highest iDAScore® will be proposed selected for transfer.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>iDAScore®</intervention_name>
    <description>Images of all the embryos reaching at least developmental stage of 3BB will be analyzed by iDAScore®. The embryo with the highest iDAScore® will be proposed for transfer.</description>
    <arm_group_label>Embryo selection supported by iDAScore®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients undergoing IVF/ICSI-treatment with controlled ovarian stimulation with&#xD;
             gonadotrophins and the intention to treat by transfer of a single day 5 fresh&#xD;
             blastocyst on day 5.&#xD;
&#xD;
          2. At least two good quality blastocysts (GQB) on day 5 (3BB or better on the Gardner&#xD;
             scale), originating from normally fertilized oocytes (2PN).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Previous participation in this RCT&#xD;
&#xD;
          2. Concurrent participation in another investigation&#xD;
&#xD;
          3. Intention to perform any form of preimplantation genetic testing&#xD;
&#xD;
          4. Fertility preservation&#xD;
&#xD;
          5. Planned transfer on day 2-4&#xD;
&#xD;
          6. Female age &gt;42 years&#xD;
&#xD;
          7. A reduced likelihood of obtaining two good quality blastocysts on day 5 as evidenced&#xD;
             by an AFC &lt;5 (if available, AFC=antral follicle count)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johanna Schmidt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Göteborgs IVF klinik</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thorir Hardarson, PhD</last_name>
    <phone>+46708228063</phone>
    <email>thardarson@vitrolife.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Göteborgs IVF klinik</name>
      <address>
        <city>Göteborg</city>
        <zip>412 50</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <contact>
      <last_name>Johanna Schmidt, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fertilitetsenheten, Universitetssjukhuset Örebro</name>
      <address>
        <city>Örebro</city>
        <zip>703 62</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <contact>
      <last_name>Therese Bohlin</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 30, 2021</study_first_submitted>
  <study_first_submitted_qc>July 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2021</study_first_posted>
  <last_update_submitted>July 8, 2021</last_update_submitted>
  <last_update_submitted_qc>July 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Embryos</keyword>
  <keyword>Embryo scoring</keyword>
  <keyword>Blastocyst selection</keyword>
  <keyword>Pregnancy rate</keyword>
  <keyword>Live birth rate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

